Stanford University Home

Stanford News Archive

Stanford Report, September 30, 1998

Seminar on patents: 9/30/98

'Patents/Start-Up 101' to teach basics of turning concepts into products

Campus community members with novel ideas in biomedical technology can learn how to obtain patents and turn concepts into products at Patent/Start-Up 101, an Oct. 24-25 seminar co-sponsored by the Office of Technology Licensing (OTL) and the Medical Device Network (MDN).

MDN was formed recently to stimulate innovation in the field of medical devices within the university, says program coordinator Sandy Miller. To learn more, call 498-7856 or send e-mail to The MDN website is at

The two-day seminar in Fairchild Auditorium at the Medical School will introduce the basics of patenting, licensing and start-up possibilities in biomedical technology. The program will include university physician inventors and entrepreneurs as well as experts in patenting, patent law, venture capital and the biomedical technology industry. Entrepreneurial faculty and the local medical device community will provide university and real-world perspectives via lectures, debate and interactive workshops.

Cost for students, residents and fellows is $15; for university faculty, $35; for non-university attendees, $145.

Register online at or call 498-7629.



Patenting and Licensing

Saturday, Oct. 24, from 8:30 a.m. to 3:30 p.m.

Setting the Stage

Technology transfer in academic medicine

Biotechnology in California

Basics of Patenting and Licensing

The role of the Office of Technology Licensing (OTL)

How to protect an idea

Elements of a medical technology patent

Lunch Break-Outs

When and how do I file my patent?

Assessing market potential

How OTL can help


Analyzing royalty structures

Benefits of licensing versus start-up

Voices of Experience, Part I

Successful faculty entrepreneurs

Start-Ups and Academics

Sunday, Oct. 25, from 9 a.m. to 3:30 p.m.

Bioengineering at Stanford

Entrepreneurship and the university

New directions in Stanford bioengineering

Academics and Entrepreneurship

Conflict of interest: university guidelines

Start-Ups, VCs, Angels and IPOs

Ingredients for a successful start-up

The role of the venture capitalist

Incubators and other funding options

Lunch Break-Outs

Strategies for funding

Issues for the doctor/founder

How to write a business plan

Voices of Experience, Part II

Future directions in biomedical technology


Stanford Faculty

John Adler, professor of neurosurgery

Thomas Byers, associate professor of industrial engineering, Technology Ventures Program in the School of Engineering

Mildred Cho, Center for Biomedical Ethics

Michael Dake, associate professor of radiology, Interventional Radiology

Peter Fitzgerald, assistant professor of medicine

Thomas Fogarty, professor of surgery

Phyllis Gardner, senior associate dean of education, Student Affairs, School of Medicine

James Gibbons, special counsel, President's Office

Bob Hu, Department of Medicine

Patricia Jones, associate dean of research

Aaron Kaplan, Department of Medicine

Gregory Kovacs, associate professor of electrical engineering

Katharine Ku, director, Office of Technology Licensing

Luis Mejia, senior associate, Office of Technology Licensing

Robert Robbins, assistant professor of cardiothoracic surgery

Matthew Selmon, Department of Medicine

John Simpson, Department of Medicine

Jessica Smith, licensing associate, Office of Technology Licensing

Simon Stertzer, professor of medicine

John Stevens, Department of Cardiothoracic Surgery

Paul Yock, professor of medicine


Legal Communitys

Bret Field, Bozicevec & Reed

James Geriak, Lyon & Lyon

Joshua Green, Venture Law Group

James Heslin, Townsend, Townsend & Crew

Edward Lynch, Heller, Ehrman, White & McAuliffe

J. Casey McGlynn, Wilson, Sonsini, Goodrich & Rosati

Medical Industry

Michael Baker, president and CEO, ArthroCare

Rich Ferrari, CEO, CardioThoracic Systems

David Gollaher, president, California Health Care Institute

Ginger Graham, president, GUIDANT

Milton McColl, president and CEO, CSFluids

William New, chairman, Natus Medical

Carl Simpson, senior vice president, GUIDANT

Allan Will, CEO, The Foundry


Venture Community

Brook Byers, Kleiner, Perkins, Caufield & Byers

David Douglass, Delphi BioVentures

Russell Hirsch, Mayfield Fund

Ross Jaffe, Brentwood Associates

Thomas McConnell, New Enterprise Associates

Robert Momsen, Interwest Partners

James Strand, Institutional Venture Partners

Petri Vainio, Sierra Ventures

Mark Wan, Three Arch Partners

Phillip Young, U.S. Venture Partners SR